Royal Bank of Canada’s Cardiol Therapeutics CRDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28K | Buy |
20,304
+7,490
| +58% | +$10.3K | ﹤0.01% | 5769 |
|
|
2025
Q1 | $12K | Sell |
12,814
-11,987
| -48% | -$11.2K | ﹤0.01% | 5701 |
|
|
2024
Q4 | $32K | Buy |
24,801
+671
| +3% | +$866 | ﹤0.01% | 5405 |
|
|
2024
Q3 | $48K | Sell |
24,130
-2,975
| -11% | -$5.92K | ﹤0.01% | 5253 |
|
|
2024
Q2 | $55K | Buy |
27,105
+10,676
| +65% | +$21.7K | ﹤0.01% | 5213 |
|
|
2024
Q1 | $31K | Sell |
16,429
-17,678
| -52% | -$33.4K | ﹤0.01% | 5282 |
|
|
2023
Q4 | $28K | Sell |
34,107
-10,342
| -23% | -$8.49K | ﹤0.01% | 5665 |
|
|
2023
Q3 | $40K | Buy |
44,449
+5,728
| +15% | +$5.16K | ﹤0.01% | 5403 |
|
|
2023
Q2 | $34K | Sell |
38,721
-13,905
| -26% | -$12.2K | ﹤0.01% | 5497 |
|
|
2023
Q1 | $25K | Buy |
52,626
+26,475
| +101% | +$12.6K | ﹤0.01% | 5552 |
|
|
2022
Q4 | $13K | Sell |
26,151
-3,288
| -11% | -$1.64K | ﹤0.01% | 5970 |
|
|
2022
Q3 | $30K | Buy |
29,439
+6,125
| +26% | +$6.24K | ﹤0.01% | 5485 |
|
|
2022
Q2 | $31K | Sell |
23,314
-11,900
| -34% | -$15.8K | ﹤0.01% | 5456 |
|
|
2022
Q1 | $54K | Buy |
35,214
+14,020
| +66% | +$21.5K | ﹤0.01% | 5550 |
|
|
2021
Q4 | $39K | Buy |
21,194
+6,999
| +49% | +$12.9K | ﹤0.01% | 5977 |
|
|
2021
Q3 | $59K | Buy |
+14,195
| New | +$59K | ﹤0.01% | 5549 |
|